{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:03:48Z","timestamp":1791669828301,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.nmd.2016.08.011","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T12:11:31Z","timestamp":1472040691000},"page":"760-767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"26","author":[{"given":"Cuixia","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda L.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Hornung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane C.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Rybalsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilan M.","family":"Rutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nmd.2016.08.011_bib0010","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2016.08.011_bib0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1212\/01.WNL.0000148485.00049.B7","article-title":"Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society","volume":"64","author":"Moxley","year":"2005","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.nmd.2016.08.011_bib0020","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJM198906153202405","article-title":"Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy","volume":"320","author":"Mendell","year":"1989","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.nmd.2016.08.011_bib0025","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/1097-4598(200009)23:9<1344::AID-MUS4>3.0.CO;2-F","article-title":"A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy","volume":"23","author":"Bonifati","year":"2000","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.nmd.2016.08.011_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003725.pub3","article-title":"Glucocorticoid corticosteroids for Duchenne muscular dystrophy","author":"Manzur","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.nmd.2016.08.011_bib0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nmd.2006.01.010","article-title":"Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade","volume":"16","author":"Biggar","year":"2006","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.nmd.2016.08.011_bib0040","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00246-005-0909-4","article-title":"Steroid therapy and cardiac function in Duchenne muscular dystrophy","volume":"26","author":"Markham","year":"2005","journal-title":"Pediatr Cardiol"},{"issue":"12","key":"10.1016\/j.nmd.2016.08.011_bib0045","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2106\/JBJS.L.01577","article-title":"Glucocorticoid treatment for the prevention of scoliosis in children with Duchenne muscular dystrophy: long-term follow-up","volume":"95","author":"Lebel","year":"2013","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"10.1016\/j.nmd.2016.08.011_bib0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/000992280304200408","article-title":"Vertebral fractures in boys with Duchenne muscular dystrophy","volume":"42","author":"Bothwell","year":"2003","journal-title":"Clin Pediatr (Phila)"},{"issue":"19","key":"10.1016\/j.nmd.2016.08.011_bib0055","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1212\/01.wnl.0000260974.41514.83","article-title":"Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy","volume":"68","author":"King","year":"2007","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2016.08.011_bib0060","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/165019701750300609","article-title":"Fracture risk in patients with muscular dystrophy and spinal muscular atrophy","volume":"33","author":"Vestergaard","year":"2001","journal-title":"J Rehabil Med"},{"issue":"9","key":"10.1016\/j.nmd.2016.08.011_bib0065","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00198-003-1443-y","article-title":"Bone mineral density and bone metabolism in Duchenne muscular dystrophy","volume":"14","author":"Bianchi","year":"2003","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.nmd.2016.08.011_bib0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/01241398-200001000-00016","article-title":"Bone mineral density and fractures in boys with Duchenne muscular dystrophy","volume":"20","author":"Larson","year":"2000","journal-title":"J Pediatr Orthop"},{"issue":"11\u201312","key":"10.1016\/j.nmd.2016.08.011_bib0075","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.nmd.2007.05.008","article-title":"Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy","volume":"17","author":"Soderpalm","year":"2007","journal-title":"Neuromuscul Disord"},{"issue":"9\u201310","key":"10.1016\/j.nmd.2016.08.011_bib0080","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.nmd.2006.05.236","article-title":"Bone health in Duchenne muscular dystrophy","volume":"16","author":"Wong","year":"2006","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"10.1016\/j.nmd.2016.08.011_bib0085","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1359\/jbmr.060601","article-title":"Association between bone mass and fractures in children: a prospective cohort study","volume":"21","author":"Clark","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.nmd.2016.08.011_bib0090","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0960-8966(01)00307-8","article-title":"Vertebral compression in Duchenne muscular dystrophy following deflazacort","volume":"12","author":"Talim","year":"2002","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.nmd.2016.08.011_bib0095","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.091007","article-title":"The relationship between fractures and DXA measures of BMD in the distal femur of children andadolescents with cerebral palsy or muscular dystrophy","volume":"25","author":"Henderson","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.nmd.2016.08.011_bib0100","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mus.23963","article-title":"Skeletal health in Duchenne dystrophy: bone-size and subcranial dual-energy X-ray absorptiometry analyses","volume":"49","author":"King","year":"2014","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.nmd.2016.08.011_bib0105","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.nmd.2012.06.354","article-title":"Bone health in boys with Duchenne Muscular Dystrophy on long-term daily deflazacort therapy","volume":"22","author":"Mayo","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2016.08.011_bib0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/bonekey.2012.5","article-title":"Insights into bone health in Duchenne muscular dystrophy","volume":"1","author":"Morgenroth","year":"2012","journal-title":"Bonekey Rep"},{"issue":"11","key":"10.1016\/j.nmd.2016.08.011_bib0115","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1007\/s00198-012-1911-3","article-title":"The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy","volume":"23","author":"Sbrocchi","year":"2012","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.nmd.2016.08.011_bib0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.nmd.2016.08.011_bib0125","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/jbmr.473","article-title":"Optimal monitoring time interval between DXA measures in children","volume":"26","author":"Shepherd","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.nmd.2016.08.011_bib0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0169-6009(92)90712-M","article-title":"Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry","volume":"17","author":"Kroger","year":"1992","journal-title":"Bone Miner"},{"issue":"2","key":"10.1016\/j.nmd.2016.08.011_bib0135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbmr.5650070204","article-title":"New approaches for interpreting projected bone densitometry","volume":"7","author":"Carter","year":"1992","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.nmd.2016.08.011_bib0140","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jocd.2014.01.003","article-title":"Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD pediatric official positions","volume":"17","author":"Crabtree","year":"2014","journal-title":"J Clin Densitom"},{"issue":"6","key":"10.1016\/j.nmd.2016.08.011_bib0145","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/ajcn\/60.6.837","article-title":"Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants","volume":"60","author":"Prentice","year":"1994","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.nmd.2016.08.011_bib0150","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/ajcn\/78.2.350","article-title":"Bone mineral content, not bone mineral density, is the correct bone measure for growth studies","volume":"78","author":"Heaney","year":"2003","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"10.1016\/j.nmd.2016.08.011_bib0160","first-page":"574","article-title":"Gradients of functional ability of importance in rehabilitation of patients with progressive muscular and neuromuscular diseases","volume":"38","author":"Swinyard","year":"1957","journal-title":"Arch Phys Med Rehabil"},{"issue":"10","key":"10.1016\/j.nmd.2016.08.011_bib0165","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1210\/jc.2011-1111","article-title":"Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study","volume":"96","author":"Zemel","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nmd.2016.08.011_bib0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jocd.2009.01.005","article-title":"Revised pediatric reference data for the lateral distal femur measured by Hologic Discovery\/Delphi dual-energy X-ray absorptiometry","volume":"12","author":"Zemel","year":"2009","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.nmd.2016.08.011_bib0180","first-page":"1","article-title":"2000 CDC Growth Charts for the United States: methods and development","author":"Kuczmarski","year":"2002","journal-title":"Vital Health Stat 11"},{"issue":"11","key":"10.1016\/j.nmd.2016.08.011_bib0185","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.nmd.2010.07.272","article-title":"170th ENMC International Workshop: bone protection for corticosteroid treated Duchenne muscular dystrophy. 27\u201329 November 2009, Naarden, The Netherlands","volume":"20","author":"Quinlivan","year":"2010","journal-title":"Neuromuscul Disord"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896616300414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896616300414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:04:56Z","timestamp":1760774696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896616300414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0960896616300414"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2016.08.011","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2016.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}